Influence of HbA1c and BMI on lipid trajectories in youths and young adults with type 1 diabetes

Diabetes Care

Volumn 40, Issue 1, 2017, Pages 30-37

  Katz, Michelle L ^a   Kollman, Craig R ^b   Dougher, Carly E ^a   Mubasher, Mohamed ^b   Laffel, Lori M B ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; AGE; ARTICLE; BODY MASS; CHILD; COHORT ANALYSIS; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; RETROSPECTIVE STUDY; SCHOOL CHILD; YOUNG ADULT; AGING; BLOOD; PATHOPHYSIOLOGY;

ADOLESCENT; AGING; BODY MASS INDEX; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85008174185     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-0430     Document Type: Article

References (35)

1. Harjutsalo V, Maric-Bilkan C, Forsblom C, Groop PH. Impact of sex and age at onset of diabetes on mortality from ischemic heart disease in patients with type 1 diabetes. Diabetes Care 2014;37:144-148
2. Orchard TJ, Stevens LK, Forrest KY, Fuller JH. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. Int J Epidemiol 1998;27:976-983
3. Krolewski AS, Kosinski EJ, Warram JH, et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987;59: 750-755
4. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010;53:2312-2319
5. Groop PH, Thomas MC, Moran JL, et al.; FinnDiane Study Group. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 2009;58: 1651-1658
6. Livingstone SJ, Levin D, Looker HC, et al.; Scottish Diabetes Research Network epidemiology group; Scottish Renal Registry. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA 2015;313:37-44
7. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014;371:1972-1982
8. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics 2011;128(Suppl. 5): S213-S256
9. American Diabetes Association. Children and adolescents. Sec. 11. In Standards of Medical Care in Diabetes-2015. Diabetes Care 2015; 38(Suppl. 1):S70-S76
10. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K; American Heart Association. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003;107:1562-1566
11. Kershnar AK, Daniels SR, Imperatore G, et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study. J Pediatr 2006;149: 314-319
12. Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jørgensen K; Norwegian Study Group for Childhood Diabetes. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: A population-based study. Diabetologia 2008;51:554-561
13. Raile K, Galler A, Hofer S, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care 2007; 30:2523-2528
14. Maahs DM, Dabelea D, D'Agostino RB Jr, et al.; SEARCH for Diabetes in Youth Study. Glucose control predicts 2-year change in lipid profile in youthwith type 1 diabetes. J Pediatr 2013; 162:101-7.e1
15. Katz ML, Volkening LK, Butler DA, Anderson BJ, Laffel LM. Family-based psychoeducation and Care Ambassador intervention to improve glycemic control in youth with type 1 diabetes: A randomized trial. Pediatr Diabetes 2014;15: 142-150
16. Laffel LM, Vangsness L, Connell A, Goebel-Fabbri A, Butler D, Anderson BJ. Impact of ambulatory, family-focused teamwork intervention on glycemic control in youth with type 1 diabetes. J Pediatr 2003;142:409-416
17. Svoren BM, Butler D, Levine BS, Anderson BJ, Laffel LMB. Reducing acute adverse outcomes in youths with type 1 diabetes: A randomized, controlled trial. Pediatrics 2003;112:914-922
18. Katz ML, Volkening LK, Anderson BJ, Laffel LM. Contemporary rates of severe hypoglycaemia in youthwith type 1 diabetes: variability by insulin regimen. Diabet Med 2012;29:926-932
19. Centers for Disease Control and Prevention. A SAS Programfor the CDC Growth Charts [article online], 2005. Available from http://www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm. Accessed 12 December 2013
20. McDowell MA, Fryar CD, Hirsch R, Ogden CL. Anthropometric reference data for children and adults: U.S. population, 1999-2002. Adv Data 2005;361:1-5
21. Langsted A, Nordestgaard BG. Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. Clin Chem 2011;57:482-489
22. Neuhaus JM, Kalbfleisch JD. Between-and within-cluster covariate effects in the analysis of clustered data. Biometrics 1998;54:638-645
23. Porkka KV, Viikari JS, Taimela S, Dahl M, Akerblom HK. Tracking and predictiveness of serum lipid and lipoprotein measurements in childhood: A 12-year follow-up. The Cardiovascular Risk in Young Finns study. Am J Epidemiol 1994;140:1096-1110
24. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels: The Muscatine Study. Pediatrics 1988;82:309-318
25. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277-2283
26. Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: The Bogalusa Heart Study. JAMA 2003;290:2271-2276
27. Loria CM, Liu K, Lewis CE, et al. Early adult risk factor levels and subsequent coronary artery calcification: The CARDIA Study. J Am Coll Cardiol 2007;49:2013-2020
28. Petitti DB, Imperatore G, Palla SL, et al.; SEARCH for Diabetes in Youth Study Group. Serum lipids and glucose control: The SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med 2007;161:159-165
29. Reh CM, Mittelman SD, Wee CP, Shah AC, Kaufman FR, Wood JR. A longitudinal assessment of lipids in youth with type 1 diabetes. Pediatr Diabetes 2011;12:365-371
30. Kuryan RE, Jacobson MS, Frank GR. Non-HDL-cholesterol in an adolescent diabetes population. J Clin Lipidol 2014;8:194-198
31. Maahs DM, Wadwa RP, McFann K, et al. Longitudinal lipid screening and use of lipidlowering medications in pediatric type 1 diabetes. J Pediatr 2007;150:146-150
32. Steiner MJ, Skinner AC, Perrin EM. Fasting might not be necessary before lipid screening: A nationally representative cross-sectional study. Pediatrics 2011;128:463-470
33. Katz ML, Telo GH, Cartaya JB, Dougher CE, DingM, Laffel LM. Under-management of hyperlipidemia in young persons with type 1 diabetes (T1D). Endocr Rev 2015;36:OR01-OR03
34. Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr 2009;9:79
35. Lebenthal Y, Horvath A, Dziechciarz P, Szajewska H, Shamir R. Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials. Arch Dis Child 2010;95: 673-680